I copied this post from AEGY to bring here and ask for

New Post Public Reply Private Reply Replies (4) Message Board
Zoofire
I copied this post from AEGY to bring here and ask for comments. When I went back to get the link to include here, the post had been removed. I'd like to hear what others think of this.

A PLAN FOR STOPPING SEC HALTS ON MJ STOCKS:

Dear Fellow Marijuana Stock Investors,

I have come up with an idea that may assist in ending these illegal targeted trading halts by the SEC. I will need the help of the community in executing this idea.

Let us start with the basics. What the SEC has done over the last few months is blatantly illegal. As a federal agency put in charge by Congress (who represent WE the people) to regulate and enforce securities laws, the SEC has no right to opine on speculation or the animal spirits in the stock market. Moreover, the SEC has no right to go on a witch hunt targeting stocks that are not directly engaged in the retailing of cannabis or are not violating any state laws.

The SEC and FINRA can issue warnings ad nauseum and warn us all about the risks involved with investing OUR hard-earned money. What they cannot do is arbitrarily destroy our capital.

What makes this entire situation even more disgusting is that they are destroying the capital of the 90% who are speculating in companies that have micro and sometimes nano valuations. In the grand scale of the overall economy or stock market these stocks represent less than a speck in the universe of fraud and speculation that takes place.

While the SEC let's hedge fund managers and investment banks engage in schemes that hurt a lot more people and cause orders of magnitude more economic damage (my 401K has still not fully recovered from the 2008 collapse, yet my marijuana stock portfolio has delivered me a 10x return), they put on this dog and pony show every time they halt (destroy) tiny companies engaged in this industry.

I am convinced that the SEC's actions fall outside the scope of the agency's charter. More importantly though, a common sense test of the situation at hand confirms that these actions certainly fall outside of what is supposed to be the spirit of the agency.

I do not for a second believe that the SEC or FINRA are protecting anyone with these trading halts. Investors that choose to speculate in penny stocks or marijuana stocks for that matter should be free to risk their hard-earned money as they see fit. If there is in fact fraud occurring then the SEC has the mandate to step in and investigate and even prosecute the wrongdoers. However, Due-Process is extremely important here and a trading halt or suspension affords no Due-Process and harms the actual investors in these companies.

The Hypocrisy doesn't end there. Take the Growlife, Inc (PHOT) situation. It has now been almost two months since the trading suspension destroyed over $200 million value for 20,000 investors and the SEC has not published one iota of evidence to support its actions. My father did not fight wars for this great nation to see us do away with the founding principles of due-process.

Our capital markets are supposed to be the most dynamic, innovative, and exciting. The marijuana stock trend was just that. On the margin, most of us made good money and good friends along the way and continue to enjoy being pioneers in this new industry.

So here is my plan:

According to my estimates there are over 100,000 of us out there. Between all the companies: MJNA, PHOT, CBIS, NVLX, HEMP, AEGY, TRTC, SKTO, MCIG, MDBX, CANN etc. etc. we are at least 100,000 strong.

Say what you say about President Obama but he does listen to his constituents. The easiest way to approach President Obama is via a White House Petition.

The url to start a petition is here:

https://petitions.whitehouse.gov/register?des...eate" rel="nofollow" target="_blank" >https://petitions.whitehouse.gov/register?destination=/petition/create

Unfortunately, I am not brave enough to start the petition as I do not want to be the torch-bearer of this movement. The purpose of my post is to share my views and knowledge of the situation at hand and hopefully empower the community to take action. I know that what is being done is wrong, and goes against the very principles which are at the heart of the SEC. If someone can start the petition, and even use some what I have written here, we can begin to distribute this around the boards and online.

I sincerely believe that we can obtain enough votes (only 5,000 required) for this petition to formally accepted. Once a petition is accepted, white house staff must provide a formal response as well as take action with the appropriate agencies.

In this case, our ask should be simple: The SEC should Cease & Desist from Arbitrarily Targeting Marijuana Related Penny-stocks by Halting Trading UNLESS they simultaneously file a formal litigation against the suspected wrongdoers with proof of the fraud that has taken place. We want Due-Process.

All we want here is for the SEC to have to actually prove that wrong-doing has occurred before being allowed to press a button and destroy our capital.

A year or so ago, there was a lot of news coverage about the IRS unfairly targeting Tea-Party related SuperPac's. That story received a lot of media attention as it was clear that the IRS was arbitrarily abusing its power. I believe that this situation with the SEC is even worst and once we have a formal petition we can all help distribute it to the media.

Good Luck, and I look forward to being one of the first signers of the petition.

SK3 Group Inc. (SKTO) Stock Research Links

SKTO Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 6

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 7

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 5

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 14

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading

Top 5 Most Recently Viewed Articles

SAP Launches Sovereign Cloud Solution in Canada for Businesses

Updated Category News Views 365

SAP Enhances Data Security with New Cloud Solutions SAP SE shares are experiencing a positive trend in premarket trading. Recently, SAP Canada introduced its innovative SAP Sovereign Cloud capabilities, which are designed to address the increasing demand from organizations for data sovereignty, robust security, and regulatory compliance. This pioneering solution enables...

Continue Reading
Corbus Pharma's Stock Drops 60%: Analysts Recommend Buying Now

Updated Category News Views 92

Corbus Pharmaceuticals Sees Significant Stock Drop Amid Market Responses Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) has recently faced a dramatic decline in its stock, plummeting by an alarming 60%. However, analysts are encouraging investors to view this as a potential buying opportunity. Firms like H.C. Wainwright and Oppenheimer have reaffirmed their buy...

Continue Reading
Manatt Welcomes New Partner with Extensive Investment Expertise

Updated Category News Views 139

Manatt's Strategic Growth in Corporate Practice Manatt, Phelps & Phillips, LLP is making waves in the corporate legal landscape with its recent addition of Peter Tsirigotis, a seasoned investment funds partner. This move reflects the firm's commitment to expanding its financial services and corporate capabilities. Based in Washington, D.C., Tsirigotis brings a wealth of...

Continue Reading
Performance Share Units Vesting: ISS A/S Updates Details

Updated Category News Views 216

Performance Share Units Vesting Announcement ISS A/S is proud to announce the significant milestone concerning its long-term incentive program (LTIP). As part of this initiative, a number of Performance Share Units (PSUs) have recently vested, leading to the delivery of ISS shares to key personnel within the company. This process, which emphasizes the company's commitment...

Continue Reading
Omnicom Boosts Dividend: New Shareholder Benefit Unveiled

Updated Category News Views 196

Omnicom Boosts Dividend for Shareholders Omnicom, a renowned leader in marketing and sales, has officially announced an increase in its quarterly dividend to $0.80 per share. This enhancement reflects a significant increase in the company's commitment to its shareholders, offering both immediate rewards and a long-term strategy for growth. Dividend Increase Overview The...

Continue Reading